{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-045016","form_type":"8-K","ticker":"NUWE","cik":"0001506492","company_name":"Nuwellis, Inc.","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.625828+00:00","generated_at":"2026-05-30T06:54:36.807926+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nuwellis reports preliminary Q3 revenue ~$2.4M, gross margin 70%, cash $1.9M","bullets":["Revenue of approximately $2.4 million; pediatric category grew 28% YoY.","Gross margin improved to 70% from 57.3% YoY; operating costs fell ~30%.","Cash used in ops ~$2.5M; cash and equivalents ~$1.9M at quarter end.","SeaStar settlement: $900K aggregate due by Dec 31, 2024; ~$500K received.","Full Q3 results and earnings call scheduled for November 11, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-045016","json":"https://secwatch.observer/filing/0001140361-24-045016.json","markdown":"https://secwatch.observer/filing/0001140361-24-045016.md","text":"https://secwatch.observer/filing/0001140361-24-045016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506492/000114036124045016/0001140361-24-045016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506492/000114036124045016/ef20037953_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:54:36.807926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}